Yaral Pharma partners with EVERSANA
Yaral Pharma the United States generics subsidiary of IBSA (Institut Biochimique SA) announced its expanding partnership with EVERSANA, a leading provider of commercialization services to the global life sciences industry, as its key commercialization partner to support the expansion of its portfoli